3,503 results match your criteria Hemangiomas Hepatic

A Giant Hepatic Hemangioma Presenting With Bilateral Pulmonary Embolism: A Case Report.

Cureus 2022 Apr 21;14(4):e24346. Epub 2022 Apr 21.

Medicine, King Abdulaziz University, Jeddah, SAU.

Hepatic hemangiomas are the most common benign tumors found in the liver. Herein, we present a case of a giant hepatic hemangioma (>4 cm) complicated by bilateral pulmonary embolism originating from the inferior vena cava thrombus with clinical and radiological features of portal hypertension. A 52-year-old woman presented to the emergency department of our institution with a history of blackouts. Read More

View Article and Full-Text PDF

Diagnostic problem of Primary Hepatic Neuroendocrine Tumor in 18-year-old woman: A case report.

Int J Surg Case Rep 2022 May 18;95:107224. Epub 2022 May 18.

Department of Radiology, Premier Surabaya Hospital, Indonesia.

Introduction And Importance: Primary Hepatic Neuroendocrine Tumor (PHNET) is a very rare case and it's quite challenging to diagnose and treat. There are approximately 300 cases reported. Among them, only two giant PHNET cases were found in children under 20 years old. Read More

View Article and Full-Text PDF

Interventional treatments for hepatic hemangioma: A state-of-the-art review.

J Interv Med 2022 Feb 26;5(1):6-9. Epub 2022 Feb 26.

Department of Radiology, Tianjin Third Central Hospital, Tianjin, 300170, China.

Hepatic hemangiomas (HHs) are the most common benign tumors of the liver. These tumors are mainly asymptomatic and do not require treatment. Nevertheless, there are some special cases that require therapeutic intervention, and surgery and intervention are currently the primary treatment modalities. Read More

View Article and Full-Text PDF
February 2022

Diffuse Hepatic Hemangiomatosis with Giant Cavernous Hemangioma in an Adult.

J Belg Soc Radiol 2022 25;106(1):17. Epub 2022 Apr 25.

Ibn Sina Teaching hospital, MA.

Although frequent, the coexistence of diffuse hepatic hemangiomatosis (DHH) with giant cavernous hemangioma (GCH) should be mentioned clearly and communicated to the referring physician for an appropriate management. Read More

View Article and Full-Text PDF

Efficacy of intravenous propranolol for life-threatening diffuse neonatal hemangiomatosis.

Pediatr Dermatol 2022 May 16. Epub 2022 May 16.

Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Oral propranolol is recommended as the first-line agent for infantile hemangioma requiring systemic treatment. Life-threatening complications such as obstructive infantile hemangioma of the airway or infantile hepatic hemangioma associated with high-output congestive heart failure are major indications for the consideration of early treatment. We present the case of an infant with life-threatening diffuse neonatal hemangiomatosis, including airway obstruction due to subglottic hemangioma, heart failure due to multiple hepatic hemangiomas with portohepatic venous shunts, and severe anemia due to continuous gastrointestinal bleeding, in which treatment with intravenous propranolol proved successful. Read More

View Article and Full-Text PDF

Radiomics Study for Differentiating Focal Hepatic Lesions Based on Unenhanced CT Images.

Front Oncol 2022 27;12:650797. Epub 2022 Apr 27.

Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Objectives: To investigate the feasibility of computer-aided discriminative diagnosis among hepatocellular carcinoma (HCC), hepatic metastasis, hepatic hemangioma, hepatic cysts, hepatic adenoma, and hepatic focal nodular hyperplasia, based on radiomics analysis of unenhanced CT images.

Methods: 452 patients with 77 with HCC, 104 with hepatic metastases, 126 with hepatic hemangioma, 99 with hepatic cysts, 24 with FNH, 22 with HA, who underwent CT examination from 2016 to 2018, were included. Radcloud Platform was used to extract radiomics features from manual delineation on unenhanced CT images. Read More

View Article and Full-Text PDF

Classification of hepatic cavernous hemangioma or hepatocellular carcinoma using a convolutional neural network model.

J Gastrointest Oncol 2022 Apr;13(2):787-791

Department of Interventional Radiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Background: Computed tomography (CT) is a common imaging technique for diagnosis of liver tumors. However, the intensity similarity on non-contrast CT images is small, making it difficult for radiologists to visually identify hepatic cavernous hemangioma (HCH) and hepatocellular carcinoma (HCC). Recently, convolutional neural networks (CNN) have been widely used in the study of medical image classification because more discriminative image features can be extracted than the human eye. Read More

View Article and Full-Text PDF

Effect of an Ultrahigh b Value of 3000 s/mm and the Minimal Echo-time on Image Quality and the T2 Shine-through Effect in Diffusion-weighted Imaging of the Liver at 3T: Phantom and Clinical Pilot Studies.

Magn Reson Med Sci 2022 May 11. Epub 2022 May 11.

Department of Radiology, Faculty of Medicine, Kyorin University.

Purpose: To assess the effect of an ultrahigh b value of 3000 s/mm and the minimal TE of 53 ms on image quality and T2 shine-through effect in liver diffusion-weighted imaging (DWI) using a 3-Tesla MRI scanner with a peak gradient of 100 mT/m.

Methods: At b values of 1000 and 3000 s/mm and at the minimal (44-53 ms) and routine TEs (70 ms), DWI of our original phantom and liver DWI in 10 healthy volunteers and 26 patients with 35 hepatic hemangiomas were acquired with this scanner, and the quantified SNR of the phantom and the hepatic parenchyma in the volunteers and the contrast-to-noise ratio (CNR) of the hepatic hemangiomas were calculated; two independent readers qualitatively graded the overall image quality in the volunteers and determined the presence or absence of the T2 shine-through effect related to the hemangiomas in the patients. We compared the SNR and subjective overall image quality between the minimal and routine TEs and the CNR and incidence of the T2 shine-through effect between b values of 1000 and 3000 s/mm. Read More

View Article and Full-Text PDF

A Retrospective Analysis of Clinical Characteristics, Treatment Modalities and Outcome of the Patients With Infantile Hepatic Hemangiomas: Single-Center Experience From Turkey.

J Pediatr Hematol Oncol 2022 May 5. Epub 2022 May 5.

Departments of Pediatric Hematology and Oncology.

Objective: Hepatic hemangiomas (HH) are the most common vascular tumors of the liver. It is important to distinguish hemangiomas from malignant liver tumors.

Materials And Methods: The patients 0 to 1 years old, were diagnosed with HH and followed up in the oncology outpatient clinic between 2009 and 2020 were included in the study. Read More

View Article and Full-Text PDF

Response to " ?" by Rajakannu et al.

J Clin Exp Hepatol 2022 Mar-Apr;12(2):718. Epub 2021 Jul 16.

Departments of General Surgery (Hepatopancreatobiliary Surgery Unit), İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.

View Article and Full-Text PDF

[Analysis of the diagnostic efficiency of combining multiple laboratory hematological indicators in alpha-fetoprotein-negative hepatocellular carcinoma].

Zhonghua Yi Xue Za Zhi 2022 May;102(17):1303-1310

School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325000, China.

To establish a diagnostic model for alpha-fetoprotein-negative hepatocellular carcinoma (AFP-NHCC) by combining multiple laboratory hematological indicators and explore its clinical diagnostic efficiency. A total of 124 inpatients, including 110 males and 14 females, aged 57 (51, 66) years, who were first diagnosed with AFP-NHCC in the PLA General Hospital were included from December 2011 to June 2017. Meanwhile, 331 cases of non-HCC were enrolled as the control group, including 279 males and 52 females, aged 58 (51, 63) years old, with 47 cases of hepatitis B virus (HBV) infection, 40 cases of liver cirrhosis, 64 cases of hepatic hemangioma or cysts, 7 cases of liver nodules, 8 cases of fatty liver, 146 cases of non-liver disease and 19 health controls. Read More

View Article and Full-Text PDF

Diffuse hepatocutaneous hemangiomatosis: an unusual presentation.

Cir Pediatr 2022 Apr 1;35(2):99-101. Epub 2022 Apr 1.

Pediatric Surgery Department. La Paz Pediatric Hospital. Madrid (Spain).

Introduction: Infantile hemangiomas with multi-organ involvement are rare, and presentation in the form of uncontrollable bleeding is exceptional.

Clinical Case: 4-day-old newborn with multiple hepatocutaneous hemangiomas and a purplish vascular lesion in the third finger of the right hand. In the third week of life, the lesion became ulcerated and caused uncontrollable bleeding. Read More

View Article and Full-Text PDF

Magnetic Resonance Features of Liver Mucinous Colorectal Metastases: What the Radiologist Should Know.

J Clin Med 2022 Apr 15;11(8). Epub 2022 Apr 15.

Division of Epatobiliary Surgical Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli, 80131 Naples, Italy.

Purpose: The aim of this study is to assess MRI features of mucinous liver metastases compared to non-mucinous metastases and hepatic hemangioma.

Methods: A radiological archive was assessed from January 2017 to June 2021 to select patients subjected to liver resection for CRCLM and MRI in the staging phase. We selected 20 patients with hepatic hemangioma (study group B). Read More

View Article and Full-Text PDF

Hepatic epithelioid hemangioendothelioma-report of three cases of a puzzling tumor.

Indian J Pathol Microbiol 2022 Apr-Jun;65(2):429-432

Department of Surgical Gastroenterology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.

Hepatic epithelioid hemangioendothelioma (EHE) is a rare malignant vascular neoplasm with unpredictable clinical behavior. These lesions are frequently misdiagnosed owing to its non-specific symptomatology, ambiguous radiological features, and overlapping histomorphology. We report three cases of hepatic EHE, of which one was male and two were female patients. Read More

View Article and Full-Text PDF

"De novo" brain arteriovenous malformation in a child with congenital porto-systemic shunt and multisystemic angiomas.

Clin Neurol Neurosurg 2022 Jun 31;217:107236. Epub 2022 Mar 31.

Neurosurgery Unit, Department of Neurosciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Electronic address:

De novo arterio-venous malformations (AVMs) of the brain have been rarely previously reported, especially in the pediatric population. Although AVMs have possible connections with other diseases, the association with congenital portosystemic shunt (CPSS) has never been reported before. A child was followed for CPSS and cutaneous and hepatic angiomas. Read More

View Article and Full-Text PDF

Combined surgical treatment of giant cavernous hepatic hemangioma: A case report.

Int J Surg Case Rep 2022 Apr 2;94:107012. Epub 2022 Apr 2.

Medical Center of the Far Eastern Federal University, Aiax Settlement, 10, FEFU Campus, Building 25, Vladivostok, Russian Island 690922, Russian Federation.

Introduction And Importance: Hepatic hemangiomas are the most common benign liver tumors, which in most cases are small in size and do not require specific treatment. Giant hepatic hemangiomas are a rare pathology. The purpose of this report is to demonstrate the case of combined treatment of giant hepatic hemangioma. Read More

View Article and Full-Text PDF

Ultrasound-guided percutaneous sclerotherapy versus surgical resection in the treatment of large hepatic hemangiomas: a retrospective study.

BMC Surg 2022 Apr 7;22(1):130. Epub 2022 Apr 7.

Organ Transplant Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.

Background: It is no consensus on the best management for patients with large hepatic hemangiomas. This study was designed to evaluate the efficacy and safety of percutaneous sclerotherapy compared to surgical resection for large hepatic hemangiomas.

Methods: A total of 89 patients with large hepatic hemangiomas from single center underwent either percutaneous sclerotherapy (n = 14) or surgical resection (n = 75) as first-line treatment was retrospectively studied, followed up for 9-24 months using ultrasound. Read More

View Article and Full-Text PDF

First report of a gallbladder hemangioma coexisting with gallstones: a case report and literature review of a rare finding.

BMC Surg 2022 Apr 6;22(1):128. Epub 2022 Apr 6.

Pathology Unit, Department of Medical Sciences, University of Turin, Via Santena 7, 10126, Torino, Italy.

Background: Gallbladder hemangioma is an exceptionally rare entity, with only ten cases reported in literature hitherto. The here described case is the first report of a gallbladder hemangioma coexisting with gallstones.

Case Presentation: A 76-year-old male was hospitalized following repeated episodes of epigastric pain. Read More

View Article and Full-Text PDF

The Image Quality and Diagnostic Performance of CT with Low-Concentration Iodine Contrast (240 mg Iodine/mL) for the Abdominal Organs.

Diagnostics (Basel) 2022 Mar 19;12(3). Epub 2022 Mar 19.

Department of Radiology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Korea.

Purpose: To evaluate the difference between CT examinations using 240 mgI/mL contrast material (CM) and 320 mgI/mL CM in the contrast enhancement of the abdominal organs and the diagnostic performance for focal hepatic lesions.

Materials And Methods: This retrospective study included 422 CT examinations, using 240 mgI/mL iohexol (Group A, 206 examinations) and 320 mgI/mL ioversol (Group B, 216 examinations), performed between April 2019 and May 2020. Two CT scanners (single-source CT (machine A) and dual-source CT (machine B)) were used to obtain CT images. Read More

View Article and Full-Text PDF

Primary hepatic neuroendocrine neoplasm diagnosed by somatostatin receptor scintigraphy: A case report.

World J Clin Cases 2022 Mar;10(7):2222-2228

Division of Hepatobiliary-pancreatic Surgery, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo 105-8470, Japan.

Background: Primary hepatic neuroendocrine neoplasm (NEN) is a rare condition, and it is difficult to differentiate between primary and metastatic hepatic NENs. Herein, we report a case of primary hepatic NEN that initially mimicked a hemangioma but showed a gradual increase in size on long-term careful observation.

Case Summary: A 47-year-old woman was incidentally diagnosed with a 12-mm liver mass, suspected to be a hemangioma. Read More

View Article and Full-Text PDF

[Urine metabolomics study of hepatocellular carcinoma].

Zhonghua Zhong Liu Za Zhi 2022 Mar;44(3):252-259

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

To investigate the urinary small molecular metabolites and their metabolic characteristics of patients with hepatocellular carcinoma (HCC). High throughput ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) was used to detect the small molecular metabolites in urine of healthy control (=10), patients with hepatic hemangioma (=10) and patients with HCC (=10). The orthogonal projections to latent structures-discriminant analysis (OPLS-DA), hierarchical cluster analysis of multivariate analysis and univariate analysis were used to analyze the differential metabolites of the three groups. Read More

View Article and Full-Text PDF

A sonographic software program, Fluctuational Imaging, for diagnosis of hepatic hemangioma.

Sci Rep 2022 03 18;12(1):4701. Epub 2022 Mar 18.

Division of Endoscopy and Ultrasound, Department of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan.

Hepatic hemangioma is the most common benign solid lesion of the liver. Contrast-enhanced computed tomography or magnetic resonance imaging is recommended for definitive diagnosis of hepatic hemangioma. However, these modalities have drawbacks in terms of radiation exposure, invasiveness, and high cost for examination. Read More

View Article and Full-Text PDF

Rare Case of Cavernous Haemangioma of the Right Atrium with Probable Hepatic Haemangioma.

Sally Harrison

Case Rep Cardiol 2022 27;2022:9214196. Epub 2022 Feb 27.

Dunedin Public Hospital, Dunedin, New Zealand.

Cardiac haemangiomas are rare causes of atrial masses. This case report is of a 44-year-old male who presented with a right atrial mass that was found incidentally on a CT performed for renal colic. The mass was further investigated with a transthoracic echocardiogram that showed that it was echodense and arising from the Eustachian valve in the right atrium. Read More

View Article and Full-Text PDF
February 2022

Tumour to tumour metastasis: case of a carotid body paraganglioma metastatic to a hepatocellular adenoma.

BMJ Case Rep 2022 Mar 2;15(3). Epub 2022 Mar 2.

Surgery, The University of British Columbia, Vancouver, British Columbia, Canada.

Tumour to tumour metastases are uncommon, and we report a case of carotid body paraganglioma metastatic to a hepatocellular adenoma. A 54-year-old man presented after a CT chest for chronic cough that incidentally identified two liver lesions in segment 3 and caudate. The imaging findings were suspicious for atypical haemangiomas versus hepatocellular adenoma. Read More

View Article and Full-Text PDF

Hyalinised hepatic haemangioma mimicking malignancy: an incidental finding.

BMJ Case Rep 2022 Mar 1;15(3). Epub 2022 Mar 1.

Radio-diagnosis, Pacific Institute of Medical Sciences Umarda Campus, Udaipur, India.

View Article and Full-Text PDF

Spontaneous evolution patterns of focal congenital hepatic hemangiomas: a case series of 25 patients.

Pediatr Radiol 2022 May 28;52(6):1048-1060. Epub 2022 Feb 28.

Department of Pediatric Radiology, Bicêtre Hospital, 78 Rue du Général Leclerc, 94270, Le Kremlin-Bicêtre, France.

Background: Hepatic hemangiomas are the most common benign liver tumors of infancy. They are termed congenital if fully developed at birth or infantile if they appear in the first weeks of life. Previous studies suggested that most focal hepatic hemangiomas are congenital in nature, exhibit no postnatal growth and have an evolution that parallels their cutaneous counterparts. Read More

View Article and Full-Text PDF

Atenolol as treatment for hepatic hemangiomas in a premature infant.

Pediatr Neonatol 2022 May 6;63(3):317-318. Epub 2022 Jan 6.

Department of Dermatology, Liverpool Hospital, Australia; Faculty of Medicine, University of New South Wales, Australia.

View Article and Full-Text PDF

Presentation of Congenital Portosystemic Shunts in Children.

Children (Basel) 2022 Feb 11;9(2). Epub 2022 Feb 11.

Swiss Pediatric Liver Center, University Hospitals Geneva (HUG), University of Geneva, 1211 Geneva, Switzerland.

Background: Congenital portosystemic shunts (CPSS) are rare vascular anomalies resulting in communications between the portal venous system and the systemic venous circulation, affecting an estimated 30,000 to 50,000 live births. CPSS can present at any age as a multi-system disease of variable severity mimicking both common and rare pediatric conditions.

Case Presentations: Case A: A vascular malformation was identified in the liver of a 10-year-old girl with tall stature, advanced somatic maturation, insulin resistance with hyperinsulinemia, hyperandrogenemia and transient hematuria. Read More

View Article and Full-Text PDF
February 2022

Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.

Curr Oncol 2022 01 30;29(2):698-723. Epub 2022 Jan 30.

Faculty of Medicine, University of Belgrade, Dr Subotica No. 8, 11000 Belgrade, Serbia.

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malignancy, with mass-forming growth pattern being the most common. The typical imaging appearance of mass-forming ICC (mICC) consists of irregular ring enhancement in the arterial phase followed by the progressive central enhancement on portal venous and delayed phases. However, atypical imaging presentation in the form of hypervascular mICC might also be seen, which can be attributed to distinct pathological characteristics. Read More

View Article and Full-Text PDF
January 2022